Safety and Efficacy of the AbsnowTM II Absorbable Atrial Septal Defect Closure System for Atrial Septal Defect Closure Therapy
A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 236 participants.
Also called NCT07529028
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 236 participants
- Sponsor
- Registry
-
NCT07529028
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Not reported
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT07529028. Randomized; no masking; primary purpose treatment. Start 2026-04 (anticipated); primary completion 2027-12 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Safety and Efficacy of the AbsnowTM II Absorbable Atrial Septal Defect Closure System for Atrial Septal Defect Closure Therapy
- Condition
- Atrial Septal Defect
- Intervention (Device)
- Absnow II Absorbable Atrial Septal Defect Occluder System
- Intervention (Device)
- Cera Atrial Septal Defect Occluder
- Lead sponsor
- Lifetech Scientific (Shenzhen) Co., Ltd.
- Collaborator
- Chinese Academy of Medical Sciences, Fuwai Hospital
- Collaborator
- Fuwai Yunnan Cardiovascular Hospital
- Collaborator
- Guangdong Provincial People's Hospital
- Collaborator
- Chinese PLA General Hospital
- Collaborator
- Lanzhou University Second Hospital
- Collaborator
- The Children's Hospital of Zhejiang University School of Medicine
- Collaborator
- Beijing Anzhen Hospital
Record details
- Record id
cardio:ct-nct07529028- Content hash
2230090747d39c67be4b0df5c77c301feb5aaf9d143e2129501fb836b8423fac